SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-010433
Filing Date
2024-04-05
Accepted
2024-04-05 16:55:41
Documents
1
Period of Report
2024-04-03

Document Format Files

Seq Description Document Type Size
1 form4-04052024_040430.html 4  
1 form4-04052024_040430.xml 4 15170
  Complete submission text file 0001415889-24-010433.txt   16616
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Issuer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KEROS THERAPEUTICS, INC. 99 HAYDEN AVENUE, SUITE 120, BUILDING E LEXINGTON MA 02421
Business Address
Farzan Nima (Reporting) CIK: 0001808296 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39743 | Film No.: 24827214